Who invested in Turn Therapeutics?
Turn Therapeutics's investors include The Global Emerging Markets Gem.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$8.7Mraised across 2 rounds since 2026, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $1.6M sold, first sale Aug 2026
Turn Therapeutics filed 2 raises, $1.9M in all. Filings say how much was sold and to how many investors; they never name the investors.
From Turn Therapeutics's own website: 1 founder, 5 on the team.
AdvisersJeffrey BunderPeter Gould
Turn Therapeutics's investors include The Global Emerging Markets Gem.
Turn Therapeutics has raised $8.7M across 2 rounds since 2026.
Turn Therapeutics's most recent round, $1.6M, was in Aug 2026.
Turn Therapeutics's largest round on record is $7.0M (Debt), in Mar 2026.
Turn Therapeutics's first round on record, in Mar 2026, was backed by The Global Emerging Markets Gem.
Turn Therapeutics's latest named round is a Debt, in Mar 2026.
Turn Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.